{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T22:33:55Z","timestamp":1766788435036,"version":"3.40.5"},"reference-count":22,"publisher":"Informa UK Limited","issue":"20","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.2217\/fon-2021-1523","type":"journal-article","created":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T08:48:12Z","timestamp":1652950092000},"page":"2533-2543","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":10,"title":["Prolonged administration of aprepitant improves cisplatin-based chemotherapy-induced nausea and vomiting"],"prefix":"10.1080","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3786-8148","authenticated-orcid":false,"given":"Yanying","family":"Li","sequence":"first","affiliation":[{"name":"Department of Thoracic Oncology,West China Hospital of Sichuan University,\rChengdu,\rChina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, West China Hospital,Sichuan University,\rChengdu,\rChina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Oncology,Sichuan Provincial Cancer Hospital,\rChengdu,\rChina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Oncology & Hematology,\rThe 452nd Hospital of PLA,\rChengdu,\rChina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Chen","sequence":"additional","affiliation":[{"name":"The Center of Lung Cancer,\rNo.7 People\u2019s Hospital of Chengdu,\rChengdu,\rChina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Oncology,The People\u2019s Hospital of Sichuan Province,\rChengdu,\rChina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of IVF,West China Second Hospital of Sichuan University,\rChengdu,\rChina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5496-8450","authenticated-orcid":false,"given":"Jiang","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Oncology,West China Hospital of Sichuan University,\rChengdu,\rChina"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,5,19]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-18-0569"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2014.225"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2018.08.006"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2015.12.001"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/943618"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-016-3332-x"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.01.095"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-018-4464-y"},{"issue":"2","key":"e_1_3_6_11_1","first-page":"259","article-title":"[Chemotherapy for non-small cell lung cancer: split-dose administration of cisplatin over four consecutive days and vinorelbine ditartrate]","volume":"36","author":"Furugaki K","year":"2009","unstructured":"Furugaki K , YoshidaJ, OgawaRet al. [Chemotherapy for non-small cell lung cancer: split-dose administration of cisplatin over four consecutive days and vinorelbine ditartrate]. Gan To Kagaku Ryoho36(2), 259\u2013263 (2009).","journal-title":"Gan To Kagaku Ryoho"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2011.02637.x"},{"key":"e_1_3_6_13_1","volume-title":"MASCC Annual Meeting on Supportive Care in Cancer.","author":"Zhu J","year":"2018","unstructured":"Zhu J , LiY, LuoY, QinY, YangL, WangY. The CINV caused by multiple-day cisplatin-based highly emetogenic chemotherapy can last a long period of time in patients with NSCLC. Presented at: MASCC Annual Meeting on Supportive Care in Cancer.Vienna, Austria, (28\u201330 June 2018). Abstract eP022"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.39.5558"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-012-1696-0"},{"issue":"5","key":"e_1_3_6_16_1","first-page":"1419","article-title":"Phase II study of palonosetron, aprepitant and dexamethasone to prevent nausea and vomiting induced by multiple-day emetogenic chemotherapy","volume":"26","author":"Ioroi T","year":"2018","unstructured":"Ioroi T , FurukawaJ, KumeMet al. Phase II study of palonosetron, aprepitant and dexamethasone to prevent nausea and vomiting induced by multiple-day emetogenic chemotherapy. Support. Care Cancer26(5), 1419\u20131423 (2018).","journal-title":"Support. Care Cancer"},{"issue":"23","key":"e_1_3_6_17_1","first-page":"3730","article-title":"Recent efficacy and safety of divided administration of high dose cisplatin in the treatment of non-small cell lung cancer: A Meta-analysis","volume":"24","author":"Dan H","year":"2016","unstructured":"Dan H , ZhangX, HuangL. Recent efficacy and safety of divided administration of high dose cisplatin in the treatment of non-small cell lung cancer: A Meta-analysis. J. Modern Oncol.24(23), 3730\u20133734 (2016).","journal-title":"J. Modern Oncol."},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.2217\/cer-2018-0089"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-014-2182-7"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2014-0229"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq149"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2005.12.001"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13736"},{"key":"e_1_3_6_24_1","first-page":"215","article-title":"Cost\u2013effectiveness of an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer in the UK","volume":"2013","author":"Samantha H","year":"2013","unstructured":"Samantha H , PellissierJ, JonesA. Cost\u2013effectiveness of an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer in the UK. Cancer Manag. Res.2013, 215\u2013224 (2013).","journal-title":"Cancer Manag. Res."}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon-2021-1523","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:46:11Z","timestamp":1719125171000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon-2021-1523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,19]]},"references-count":22,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["10.2217\/fon-2021-1523"],"URL":"https:\/\/doi.org\/10.2217\/fon-2021-1523","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"type":"print","value":"1479-6694"},{"type":"electronic","value":"1744-8301"}],"subject":[],"published":{"date-parts":[[2022,5,19]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-11-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}